AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. At the time, their cancer center served a significant cancer population in the region and maintained robust and ever-expanding PET diagnostics.

Nuclear Medicine 264

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 264

AuntMinnie

JULY 11, 2023

Pharmaceutical industry companies were involved in payments to diagnostic radiolog.

Diagnostic 100

Diagnostic Radiation Oncology Pharmaceutical Radiology 100

Imaging Technology

SEPTEMBER 20, 2023

a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for cancer detection and treatment, announced an exclusive licensing agreement for RefleXion to develop and commercialize a specific 3BP molecule to direct its SCINTIX biology-guided radiotherapy.

Pharmaceutical 105

Pharmaceutical Radiopharmaceuticals Radiation Diagnostic 105

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.

Nuclear Medicine 264

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 264

AuntMinnie

APRIL 22, 2024

The ASRT weighed in, telling AuntMinnie.com, "A key issue we continue to face is state legislation designed to weaken or remove licensure for medical imaging and radiation therapy professionals. For CT and MRI procedures where injected contrast media is ordered, ".

Radiology Technologist 264

Radiology Technologist Medicare Radiologist Basic Life Support 264

AuntMinnie

MARCH 14, 2024

Clarity Pharmaceuticals has completed its third cohort in the theranostic SECuRE trial evaluating copper-64 (Cu-64) and copper-67 (Cu-67) sarcophagine chelator technology in patients with metastatic castration-resistant prostate cancer.

Pharmaceutical 130

Pharmaceutical Diagnostic Radiation Oncology IT 130

Imaging Technology

JANUARY 8, 2024

Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.

Healthcare 105

Healthcare Healthcare Radiation Oncology Radiation 105